Dr. Zadeh's research program focuses on three main areas: genomics of nervous system tumours, tumour angiogenesis and mechanisms of resistance to therapy, and tumour metabolism. The first area of research looks at skull base tumors, such as Schwannomas and meningiomas, to advance our understanding of their molecular and genomic makeup, and identify novel therapeutic targets. The second area of research is focused on understanding the impact of anti-angiogenic therapy on tumour growth and identifying novel therapeutic strategies to improve response to this type of therapy. Finally, the third area of research is aimed at understanding how altered cancer cell metabolism contributes to tumour growth and identifying potential therapeutic targets. Overall, Dr. Zadeh's research program aims to improve our understanding of the molecular and genetic underpinnings of different types of tumours, with the ultimate goal of improving patient outcomes.
Gelareh Zadeh, MD, PhD, FRCPC, FRCSC
Senior Scientist, Princess Margaret Cancer Centre
Related Links
Senior Scientist, Princess Margaret Cancer Centre
Co-Director, Krembil Brain Institute, UHN
Head, Division of Neurosurgery, Toronto Western Hospital
Adjunct Scientist, The Hospital for Sick Children
Professor, Department of Surgery, University of Toronto
Dan Family Chair in Neurosurgery, Division of Neurosurgery, Department of Surgery, University of Toronto
Associate Member, Institute of Medical Science, University of Toronto